Model Details

Model NamePragmatic-Explanatory Continuum Indicator Summary 2
D and/or ID=I
Construct Flexibility5
Socio-Ecological LevelsIndividual
naltrexon gravid naltrexon revia naltrexon behandling
malonetta birth control antibiotikauden.site malonetta amning

Organization
Community
malonetta birth control antibiotikauden.site malonetta amning

System
malonetta birth control antibiotikauden.site malonetta amning

Figure No figure is associated with this model.
Field of OriginHealth Services Research
Practioner/ResearcherResearcher
ConstructsAdopter/implementer/decision maker characteristics

Compatibility

Context - Inner setting

Evaluation

Innovation characteristics

Outcomes - Health/QOL/Satisfaction/Clinical

Websitehttps://www.precis-2.org/
Number of Times Cited413
CitationsLoudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose BMJ 2015;350:h2147

PRECIS-2 website
https://www.precis-2.org/

Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-75.

Loudon K, Zwarenstein M, Sullivan F, et al. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose. Trials 2013;14:115.
ExamplesForbes G, Loudon K, Treweek S, Taylor SJC, Eldridge S. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2. J Clin Epidemiol. 2017 Oct;90:119-126.

Lipman PD, Loudon K, Dluzak L, Moloney R, Messner D, Stoney CM. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Trials. 2017 Nov 10;18(1):532.
User ratingsAverage rating: 0 stars based on 0 review(s).
Reviews
No Comments have been added at this time.